Athena Global Technologies Q4FY26 Results: Consolidated loss narrows to ₹1,332 lakh

ScanX News Athena Global Technologies Q4FY26 Results: Consolidated loss narrows to ₹1,332 lakh 1 min read | Published on 08 Sept 2026, 10:08 PM | Updated on 08 Sept 2026, 10:08 PM Reviewed by Anirudha B ScanX News Team Add as a preferred source on Google *this image is generated using AI for illustrative purposes only. Athena Global Technologies has scheduled its 34th Annual General Meeting (AGM) for September 30, 2026, to approve the financial statements for the fiscal year ended March 31, 2026. The meeting will be conducted via Video Conferencing or Other Audio-Visual Means (OAVM). The company reported a consolidated net loss of ₹1,332.01 lakh for FY26, a significant improvement from the ₹2,014.42 lakh loss recorded in FY25. This reduction was primarily driven by a non-operational gain of ₹2,339.75 lakh from the derecognition of investment property, which offset operating losses. Financial Performance Consolidated revenue from operations declined to ₹1,119.66 lakh in FY26, down from ₹1,562.44 lakh in the previous year. At the standalone level, revenue fell more sharply to ₹805.94 lakh from ₹1,217.80 lakh. Despite the revenue contraction, total income at the consolidated level stood at ₹1,238.84 lakh, supported by other income of ₹119.18 lakh. Metric Consolidated FY26 (₹ Lakh) Consolidated FY25 (₹ Lakh) Standalone FY26 (₹ Lakh) Standalone FY25 (₹ Lakh) Revenue from Operations 1,119.66 1,562.44 805.94 1,217.80 Total Income 1,238.84 1,628.63 1,178.46 1,465.60 Net Loss (1,332.01) (2,014.42) (3,969.50) (1,411.98) What the Numbers Show The divergence between standalone and consolidated results highlights the impact of exceptional items. While the standalone entity posted a widened net loss of ₹3,969.50 lakh due to a ₹3,235.60 lakh loss on the sale of an investment in a subsidiary, the consolidated bottom line benefited from the ₹2,339.75 lakh gain on derecognizing investment property. This suggests that the improvement in consolidated profitability is largely structural rather than operational, as core revenue streams contracted across both reporting levels. Corporate Governance and Subsidiaries The Board of Directors recommended the re-appointment of Mrs. M. Sunitha as a Director, who retires by rotation. The company has four subsidiaries: MedleyMed Healthcare Solutions Private Limited, Tutoroot Technologies Private Limited, Athena Global Technologies (UK) Limited, and Athena Global Technologies, Inc. During the year, the company restructured its healthcare vertical by acquiring 100% equity in MedleyMed Healthcare Solutions Private Limited. No dividend is recommended for FY26 due to inadequate profits. The authorized share capital remains at ₹16 crore, with issued, subscribed, and paid-up capital standing at ₹14.71 crore. Historical Stock Returns for Athena Global Technologies 1 Day 5 Days 1 Month 6 Months 1 Year 5 Years + 2. 87 % - 4. 24 % - 7. 86 % - 26. 93 % - 43. 71 % - 8. 35 % How does the ₹3,235.60 lakh loss on the sale of a subsidiary impact Athena Global's long-term strategic focus and remaining operational capabilities? fuzz it Given the 28% decline in consolidated revenue, what specific operational strategies is management implementing to reverse the core business contraction? fuzz it What are the future prospects for MedleyMed Healthcare Solutions following its full acquisition, and will it become the primary driver of revenue growth? fuzz it ScanX News Athena Global Technologies Q4FY26 Results: Consolidated loss narrows to ₹1,332 lakh 1 min read | Published on 26 May 2026, 10:55 AM | Updated on 31 May 2026, 01:54 AM Reviewed by Add as a preferred source on Google *this image is generated using AI for illustrative purposes only. Athena Global Technologies Limited reported a standalone net loss of ₹3,969.50 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹1,411.98 lakh in the previous year. The company's revenue from operations for the year stood at ₹805.94 lakh, a decrease from ₹1,217.80 lakh in FY25. The standalone financial results for the fourth quarter and fiscal year were approved by the board on May 30, 2026. The board also approved the audited consolidated financial results, which showed a net loss of ₹4,567.62 lakh for FY26. The consolidated revenue from operations for the year was ₹1,119.66 lakh, down from ₹1,562.44 lakh in the previous year. The statutory auditors, Ramanatham & Rao, Chartered Accountants, issued an unmodified opinion on both the standalone and consolidated financial results. Financial Performance The company's financial performance for the year was significantly impacted by exceptional items. A loss of ₹3,235.60 lakh was recognized due to the sale of investment in subsidiary Medley Medical Solutions Private Limited. Conversely, a gain of ₹2,339.75 lakh was recorded from the derecognition of investment property following a perpetual lease agreement executed in November 2025. Metric Standalone FY26 (₹ in Lakhs) Standalone FY25 (₹ in Lakhs) Revenue from Operations 805.94 1,217.80 Total Income 1,178.46 1,465.60 Total Expenses 3,562.95 2,788.70 Net Profit/(Loss) for the period (3,969.50) (1,411.98) Earnings Per Share (Basic) (27.39) (10.05) Key Board Decisions During the meeting held on May 30, 2026, the board approved several key resolutions. M/s. Sarda & Agarwal, Chartered Accountants, were appointed as internal auditors for FY 2026-27. Additionally, the board approved a proposal to invest up to ₹50 crores in Optionally Convertible Debentures (OCDs) of Medley Medical Solutions Private Limited and Tutoroot Technologies Private Limited, in one or more tranches. The trading window for dealing in equity shares, which was closed since April 01, 2026, will remain closed until 48 hours after the financial results are announced to the public. This restriction applies to all designated persons, their immediate relatives, and connected persons in compliance with SEBI regulations. Historical Stock Returns for Athena Global Technologies 1 Day 5 Days 1 Month 6 Months 1 Year 5 Years + 2. 87 % - 4. 24 % - 7. 86 % - 26. 93 % - 43. 71 % - 8. 35 % How does the ₹50 crore OCD investment strategy signal the board's confidence in Medley Medical and Tutoroot Technologies despite recent divestments? fuzz it What specific operational measures will be implemented to reverse the declining revenue trend observed in both standalone and consolidated segments? fuzz it With the perpetual lease agreement finalized, how does the company plan to utilize the capital gains from the investment property derecognition? fuzz it view all Athena Global Technologies Submits EGM Voting Results to BSE Mar 27, 2026 Athena Global Technologies Approves Q1 Results, Converts Warrants to Equity Aug 11, 2025 Athena Global Technologies Withdraws NCD Issue and Approves Major Property Sale/Lease Feb 27, 2025 Athena Global Technologies Withdraws ₹150 Crore NCD Issue, Approves SEZ Property Sale/Lease Feb 25, 2025